We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleMemantine for cognitive impairment in multiple sclerosis: a randomized placebo-controlled trial.AuthorsLovera, J F; Frohman, E; Brown, T R; Bandari, D; Nguyen, L; Yadav, V; Stuve, O; Karman, J; Bogardus, K; Heimburger, G; Cua, L; Remingon, G; Fowler, J; Monahan, T; Kilcup, S; Courtney, Y; McAleenan, J; Butler, K; Wild, K; Whitham, R; Bourdette, DAbstractMemantine, an NMDA antagonist, is effective for moderate to severe Alzheimer's disease.PublicationMultiple sclerosis (Houndmills, Basingstoke, England), 2010, Vol 16, Issue 6, p715ISSN1477-0970Publication typeJournal ArticleDOI10.1177/1352458510367662